Postdoctoral Associate
Contact | Publications
Qualifications:
Ph.D. in Cancer Biology
Integrated M.Sc. in Biotechnology & Bioinformatics
Skills:
Expert in molecular and cellular biology techniques including CRISPR-Cas9 gene editing, shRNA silencing, and lentiviral transduction; proficient in flow cytometry, immunofluorescence, live-cell imaging, and high-throughput drug screening using organoid and spheroid models; experienced in developing and maintaining patient-derived xenograft (PDX) models and performing advanced in vivo procedures such as surgical castration and multi-route drug delivery; highly skilled in RIME (Rapid Immunoprecipitation Mass Spectrometry of Endogenous Proteins) sample preparation and single-cell omics workflows including single-cell RNA-seq and ATAC-seq.
” My research is focused on understanding why certain prostate cancers become resistant to treatment, especially in the context of castration-resistant condition. I’m particularly interested in how non-canonical signaling through the androgen receptor (AR) and glucocorticoid receptor (GR) drives therapy resistance. A key part of my work involves exploring how post-translational modifications affect these receptors and contribute to aggressive tumor behavior. My goal is to identify new therapeutic targets and design combination strategies that can overcome resistance and improve outcomes for patients with advanced prostate cancer.”
Selected Honors & Awards:
- AACR Scholar-in-Training Award from Prostate Cancer Foundation, 2025
- Best Poster Award, Cancer Research Consortium Symposium, University at Buffalo, 2023
<- Back